Triple-negative breast cancer: disease entity or title of convenience?
Dana-Farber Cancer Institute · Harvard University · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
777
total citations
- FWCI
- 17.28
- Percentile
- 100%
- References
- 148
Citations per year
Authors
5- LALisa A. CareyCorresponding
- EPEric P. Winer
Dana-Farber Cancer Institute, Harvard University, Harvard University Press
- GVGiuseppe Viale
Ripamonti, European Institute of Oncology, University of Milan
- DCDavid Cameron
Edinburgh Cancer Research, University of Edinburgh
- LGLuca Gianni
Fondazione IRCCS Istituto Nazionale dei Tumori
Topics & keywords
Topics
Keywords
- Medicine
- Triple-negative breast cancer
- Breast cancer
- Oncology
- Internal medicine
- Targeted therapy
- Metastatic breast cancer
- Hormone receptor
No related works found for this paper.